B7-H4 expression is upregulated by PKCδ activation and contributes to PKCδ-induced cell motility in colorectal cancer

[1] Morris EJ(2010)Surgical management and outcomes of colorectal cancer liver metastases Br J Surg 97 1110-1118

[2] Forman D(2018)Development and validation of an immunity-related classifier of nine chemokines for predicting recurrence in stage I–III patients with colorectal cancer after operation Cancer Manag Res 10 4051-4064

[3] Thomas JD(2008)Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 1570-1595

[4] Quirke P(2018)Significance of lymph node metastasis in the survival of stage IV colorectal cancer by hematogenous metastasis Ann Surg Treat Res 95 201-212

[5] Taylor EF(2003)B7x: a widely expressed B7 family member that inhibits T cell activation Proc Natl Acad Sci USA 100 10388-10392

[6] Fairley L(2003)B7–H4, a molecule of the B7 family, negatively regulates T cell immunity Immunity 18 849-861

[7] Xu G(2011)The inhibitory role of b7–h4 in antitumor immunity: association with cancer progression and survival Clin Dev Immunol. 2011 695834-10396

[8] Zhou Y(2006)B7–H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival Proc Natl Acad Sci USA 103 10391-19463

[9] Zhou F(2007)B7–H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome Proc Natl Acad Sci USA 104 19458-1186

[10] Levin B(2015)Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1 Immunotherapy 7 1169-896

[1] Morris EJ(2010)Surgical management and outcomes of colorectal cancer liver metastases Br J Surg 97 1110-1118

[2] Forman D(2018)Development and validation of an immunity-related classifier of nine chemokines for predicting recurrence in stage I–III patients with colorectal cancer after operation Cancer Manag Res 10 4051-4064

[3] Thomas JD(2008)Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 1570-1595

[4] Quirke P(2018)Significance of lymph node metastasis in the survival of stage IV colorectal cancer by hematogenous metastasis Ann Surg Treat Res 95 201-212

[5] Taylor EF(2003)B7x: a widely expressed B7 family member that inhibits T cell activation Proc Natl Acad Sci USA 100 10388-10392

[6] Fairley L(2003)B7–H4, a molecule of the B7 family, negatively regulates T cell immunity Immunity 18 849-861

[7] Xu G(2011)The inhibitory role of b7–h4 in antitumor immunity: association with cancer progression and survival Clin Dev Immunol. 2011 695834-10396

[8] Zhou Y(2006)B7–H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival Proc Natl Acad Sci USA 103 10391-19463

[9] Zhou F(2007)B7–H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome Proc Natl Acad Sci USA 104 19458-1186

[10] Levin B(2015)Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1 Immunotherapy 7 1169-896